As part of D4DPR active role in the initial phases of regulatory development, we release position papers which inform lawmakers, healthcare administrators, and the public about the legal and public health implications of drug policy reform, and make evidence-based policy recommendations.
.png)
The legalization of medical cannabis in many states has made it easier for patients to access this treatment option, and the increasing acceptance of cannabis by the medical community has helped to remove the stigma associated with its use. However, more than half of medical cannabis states and most healthcare settings have not clarified the use of cannabis in healthcare facilities. The purpose of this white paper, Legislative and Administrative Guidelines for Regulating Cannabis Use in Healthcare Facilities, is to present the statute and policy language that has been used to support the use of medical cannabis in healthcare settings, providing a detailed blueprint for lawmakers, healthcare administrators, and other stakeholders interested in implementing a legal framework for the use of cannabis in healthcare facilities.
.png)
D4DPR believes that it is important to understand the limited effect that rescheduling will have on the clinical practice of cannabis medicine, the criminalization of cannabis cultivation/production, sale and use, and research. In our new policy paper “The Importance of Descheduling, Not Just Rescheduling, Cannabis in the U.S.,” (modeled after our recent letter to the White House), we highlight and address some of the significant limitations associated with rescheduling and the need to federally deschedule cannabis from the Controlled Substances Act (CSA).
%20(1).jpg)
D4DPR highlights that Overdose Prevention Centers (OPCs)—a harm reduction approach that prevents overdose deaths, reduces the transmission of infectious diseases, and improves the quality of life for individuals who use drugs—represent a wise, cost-effective, and necessary use of Opioid Settlement funds.
%20(4).jpg)
To improve public health outcomes, D4DPR supports incorporating additional safer supply options, such as prescribed heroin or other opioids, into existing regulatory frameworks.
%20(3).jpg)
D4DPR recommends the statewide decriminalization of psychedelics as a necessary step toward an evidence-based drug policy that shifts focus from punishment to public health, harm reduction, and social equity.
.svg)
